Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what extent paediatric influenza-related mortality may be prevented by a maternal vaccine since...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258953702100225X |
id |
doaj-7dc6d7e839eb4fbebbb0f621ed7fa65d |
---|---|
record_format |
Article |
spelling |
doaj-7dc6d7e839eb4fbebbb0f621ed7fa65d2021-07-29T04:23:24ZengElsevierEClinicalMedicine2589-53702021-07-0137100945Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case seriesYvette N Löwensteyn0Harish Nair1Marta C Nunes2Ichelle van Roessel3Femke S Vernooij4Joukje Willemsen5Louis J Bont6Natalie I Mazur7Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsRespiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, the Netherlands; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UKRespiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, the Netherlands; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands; Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands; Corresponding author.Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what extent paediatric influenza-related mortality may be prevented by a maternal vaccine since global age-stratified mortality data are lacking. Methods: We invited clinicians and researchers to share clinical and demographic characteristics from children younger than 5 years who died with laboratory-confirmed influenza infection between January 1, 1995 and March 31, 2020. We evaluated the potential impact of maternal vaccination by estimating the number of children younger than 3 months with in-hospital influenza-related death using published global mortality estimates. Findings: We included 314 children from 31 countries. Comorbidities were present in 166 (53%) children and 41 (13%) children were born prematurely. Median age at death was 8·6 (IQR 4·5–16·6), 11·5 (IQR 4·3–24·0), and 15·5 (IQR 7·4–27·0) months for children from low- and lower-middle-income countries (LMICs), upper-middle-income countries (UMICs), and high-income countries (HICs), respectively. The proportion of children younger than 3 months at time of death was 17% in LMICs, 12% in UMICs, and 7% in HICs. We estimated that 3339 annual influenza-related in-hospital deaths occur in the first 3 months of life globally. Interpretation: In our study, less than 20% of children is younger than 3 months at time of influenza-related death. Although maternal influenza vaccination may impact maternal and infant influenza disease burden, additional immunisation strategies are needed to prevent global influenza-related childhood mortality. The missing data, global coverage, and data quality in this study should be taken into consideration for further interpretation of the results. Funding: Bill & Melinda Gates Foundation.http://www.sciencedirect.com/science/article/pii/S258953702100225X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yvette N Löwensteyn Harish Nair Marta C Nunes Ichelle van Roessel Femke S Vernooij Joukje Willemsen Louis J Bont Natalie I Mazur |
spellingShingle |
Yvette N Löwensteyn Harish Nair Marta C Nunes Ichelle van Roessel Femke S Vernooij Joukje Willemsen Louis J Bont Natalie I Mazur Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series EClinicalMedicine |
author_facet |
Yvette N Löwensteyn Harish Nair Marta C Nunes Ichelle van Roessel Femke S Vernooij Joukje Willemsen Louis J Bont Natalie I Mazur |
author_sort |
Yvette N Löwensteyn |
title |
Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series |
title_short |
Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series |
title_full |
Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series |
title_fullStr |
Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series |
title_full_unstemmed |
Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series |
title_sort |
estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: a retrospective case series |
publisher |
Elsevier |
series |
EClinicalMedicine |
issn |
2589-5370 |
publishDate |
2021-07-01 |
description |
Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what extent paediatric influenza-related mortality may be prevented by a maternal vaccine since global age-stratified mortality data are lacking. Methods: We invited clinicians and researchers to share clinical and demographic characteristics from children younger than 5 years who died with laboratory-confirmed influenza infection between January 1, 1995 and March 31, 2020. We evaluated the potential impact of maternal vaccination by estimating the number of children younger than 3 months with in-hospital influenza-related death using published global mortality estimates. Findings: We included 314 children from 31 countries. Comorbidities were present in 166 (53%) children and 41 (13%) children were born prematurely. Median age at death was 8·6 (IQR 4·5–16·6), 11·5 (IQR 4·3–24·0), and 15·5 (IQR 7·4–27·0) months for children from low- and lower-middle-income countries (LMICs), upper-middle-income countries (UMICs), and high-income countries (HICs), respectively. The proportion of children younger than 3 months at time of death was 17% in LMICs, 12% in UMICs, and 7% in HICs. We estimated that 3339 annual influenza-related in-hospital deaths occur in the first 3 months of life globally. Interpretation: In our study, less than 20% of children is younger than 3 months at time of influenza-related death. Although maternal influenza vaccination may impact maternal and infant influenza disease burden, additional immunisation strategies are needed to prevent global influenza-related childhood mortality. The missing data, global coverage, and data quality in this study should be taken into consideration for further interpretation of the results. Funding: Bill & Melinda Gates Foundation. |
url |
http://www.sciencedirect.com/science/article/pii/S258953702100225X |
work_keys_str_mv |
AT yvettenlowensteyn estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT harishnair estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT martacnunes estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT ichellevanroessel estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT femkesvernooij estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT joukjewillemsen estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT louisjbont estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries AT natalieimazur estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries |
_version_ |
1721259520914620416 |